These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 1570015

  • 1. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
    Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J.
    Nature; 1992 Apr 23; 356(6371):713-5. PubMed ID: 1570015
    [Abstract] [Full Text] [Related]

  • 2. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N, Ricca C, Fletcher J, Glover T, Seizinger BR, Manne V.
    Cancer Res; 1995 Aug 15; 55(16):3569-75. PubMed ID: 7627966
    [Abstract] [Full Text] [Related]

  • 3. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S, Maekawa M, Nakamura S.
    Oncogene; 1992 Mar 15; 7(3):481-5. PubMed ID: 1549362
    [Abstract] [Full Text] [Related]

  • 4. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S, Bottorff D, Stone JC.
    Mol Carcinog; 1996 Jan 15; 15(1):64-9. PubMed ID: 8561868
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of rasGAP and neurofibromatosis gene product activities.
    Bollag G, McCormick F.
    Nature; 1991 Jun 13; 351(6327):576-9. PubMed ID: 1904555
    [Abstract] [Full Text] [Related]

  • 6. [Molecular genetics of neurofibromatosis type 1].
    Suzuki H, Takahashi K, Shibahara S.
    Nihon Rinsho; 1993 Sep 13; 51(9):2457-61. PubMed ID: 8411728
    [Abstract] [Full Text] [Related]

  • 7. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
    Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K.
    Nat Genet; 1996 Feb 13; 12(2):144-8. PubMed ID: 8563751
    [Abstract] [Full Text] [Related]

  • 8. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
    Weiss B, Bollag G, Shannon K.
    Am J Med Genet; 1999 Mar 26; 89(1):14-22. PubMed ID: 10469432
    [Abstract] [Full Text] [Related]

  • 9. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
    Guha A, Lau N, Huvar I, Gutmann D, Provias J, Pawson T, Boss G.
    Oncogene; 1996 Feb 01; 12(3):507-13. PubMed ID: 8637706
    [Abstract] [Full Text] [Related]

  • 10. Ras regulation. NF is enough of GAP.
    Bollag G, McCormick F.
    Nature; 1992 Apr 23; 356(6371):663-4. PubMed ID: 1570011
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
    Marshall MS, Hettich LA.
    Oncogene; 1993 Feb 23; 8(2):425-31. PubMed ID: 8426748
    [Abstract] [Full Text] [Related]

  • 12. Regulation of the Ras signaling pathway by GTPase-activating protein in PC12 cells.
    Yao R, Cooper GM.
    Oncogene; 1995 Oct 19; 11(8):1607-14. PubMed ID: 7478585
    [Abstract] [Full Text] [Related]

  • 13. Suppression of c-ras transformation by GTPase-activating protein.
    Zhang K, DeClue JE, Vass WC, Papageorge AG, McCormick F, Lowy DR.
    Nature; 1990 Aug 23; 346(6286):754-6. PubMed ID: 2201922
    [Abstract] [Full Text] [Related]

  • 14. Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway.
    Buchberg AM, Cleveland LS, Jenkins NA, Copeland NG.
    Nature; 1990 Sep 20; 347(6290):291-4. PubMed ID: 2169593
    [Abstract] [Full Text] [Related]

  • 15. Regulatory mechanisms for ras proteins.
    Downward J.
    Bioessays; 1992 Mar 20; 14(3):177-84. PubMed ID: 1586371
    [Abstract] [Full Text] [Related]

  • 16. Interactions between p21ras proteins and their GTPase activating proteins.
    Polakis P, McCormick F.
    Cancer Surv; 1992 Mar 20; 12():25-42. PubMed ID: 1386285
    [Abstract] [Full Text] [Related]

  • 17. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
    Gutmann DH, Giordano MJ, Mahadeo DK, Lau N, Silbergeld D, Guha A.
    Oncogene; 1996 May 16; 12(10):2121-7. PubMed ID: 8668337
    [Abstract] [Full Text] [Related]

  • 18. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
    Kim HA, Rosenbaum T, Marchionni MA, Ratner N, DeClue JE.
    Oncogene; 1995 Jul 20; 11(2):325-35. PubMed ID: 7624147
    [Abstract] [Full Text] [Related]

  • 19. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
    Dilworth JT, Kraniak JM, Wojtkowiak JW, Gibbs RA, Borch RF, Tainsky MA, Reiners JJ, Mattingly RR.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1485-92. PubMed ID: 16797490
    [Abstract] [Full Text] [Related]

  • 20. [NF1 (neurofibromatosis type 1)].
    Maruta H, Nur-e-Kamal.
    Gan To Kagaku Ryoho; 1997 Sep 30; 24(11):1422-6. PubMed ID: 9309135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.